Hypercalcemia in breast cancer: an echo of bone mobilization during lactation? (Q36198198)

12 August 2017

1 reference

title

Hypercalcemia in breast cancer: an echo of bone mobilization during lactation? (English)

1 reference

12 August 2017

Samantha DeMauro

1

1 reference

PubMed ID

16025222

12 August 2017

John Wysolmerski

series ordinal

2

1 reference

12 August 2017

1 April 2005

1 reference

Journal of Mammary Gland Biology and Neoplasia

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

2

1 reference

12 August 2017

157-167

1 reference

https://scigraph.springernature.com/pub.10.1007/s10911-005-5398-9

12 August 2017

0 references

cites work

The clinical course of bone metastases from breast cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10911-005-5398-9

Molecular mechanisms of osteolytic bone metastases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10911-005-5398-9

Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10911-005-5398-9

Low Estrogen and High Parathyroid Hormone-Related Peptide Levels Contribute to Accelerated Bone Resorption and Bone Loss in Lactating Mice

21 January 2018

1 reference

12 December 2020

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

1 reference

12 December 2020

The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport

1 reference

12 December 2020

Breast cancer cells interact with osteoblasts to support osteoclast formation

1 reference

12 December 2020

Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia

1 reference

12 December 2020

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel

1 reference

12 December 2020

Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue

1 reference

12 December 2020

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy

1 reference

12 December 2020

Cancer statistics, 2004

1 reference

12 December 2020

Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy

1 reference

12 December 2020

Hypercalcemia in breast cancer. Reassessment of the mechanism.

1 reference

12 December 2020

Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.

1 reference

12 December 2020

Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer

1 reference

12 December 2020

Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.

1 reference

12 December 2020

High levels of a parathyroid hormone-like protein in milk

1 reference

12 December 2020

Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation

1 reference

12 December 2020

Elevated parathyroid hormone-related peptide associated with lactation and bone density loss

1 reference

12 December 2020

Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse

1 reference

12 December 2020

Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody

1 reference

12 December 2020

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

1 reference

12 December 2020

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials

1 reference

12 December 2020

Systematic review of bisphosphonates for hypercalcaemia of malignancy

1 reference

12 December 2020

Parathyroid hormone-related protein: a developmental regulatory molecule necessary for mammary gland development

1 reference

12 December 2020

Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization

1 reference

12 December 2020

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial

1 reference

12 December 2020

Novel approaches to the management of bone metastases in patients with breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein

1 reference

12 December 2020

Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo.

1 reference

12 December 2020

Bisphosphonates: from the laboratory to the clinic and back again

1 reference

12 December 2020

Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases

1 reference

12 December 2020

Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation

1 reference

12 December 2020

Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo

1 reference

12 December 2020

Defining the roles of parathyroid hormone-related protein in normal physiology

1 reference

12 December 2020

Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate

1 reference

12 December 2020

Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines

1 reference

12 December 2020

Hypercalcemia of malignancy

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Cellular and molecular mechanisms of action of bisphosphonates

1 reference

12 December 2020

Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis

1 reference

12 December 2020

Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites

1 reference

12 December 2020

Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

1 reference

12 December 2020

Optimal frequency of administration of pamidronate in patients with hypercalcaemia of malignancy

1 reference

12 December 2020

10.1007/S10911-005-5398-9

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16025222